Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by P. acnes

Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by P. acnes

US Patent 11617748 · Granted Apr 4, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Meclozine derivatives and diclazuril derivatives for use in the prevention and/o2021
Meclozine derivatives and diclazuril derivatives for use in the prevention and/o2021
Meclozine derivatives and diclazuril derivatives for use in the prevention and/o2021
Meclozine derivatives and diclazuril derivatives for use in the prevention and/o2021
Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular po2021
Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular po2021
Hycanthone derivatives and Primaquine derivatives for use in the prevention and/2020
Hycanthone derivatives and Primaquine derivatives for use in the prevention and/2020
Hycanthone derivatives and Primaquine derivatives for use in the prevention and/2020
Hycanthone derivatives and Primaquine derivatives for use in the prevention and/2020
Isolated peptides and fragments thereof from fibrinogen for use as drugs, partic2019
Isolated peptides and fragments thereof from fibrinogen for use as drugs, partic2019